Agenda

TimeDescription
2:00 - 3:00pmRegistration and refreshments
3:00 - 3:30pm

Keynote


Steve Kozlowski, Director, Office of Biotechnology Products, FDA
3:30 - 4:00pm

Keynote


Wassim Nashabeh, Vice President, Regulatory Policy and International Operations, Roche Pharmaceutical Group
4:00 - 5:00pm

Panel Discussion


Patrick Swann, Vice President, Quality Science and Technology, Amgen

Katy Stein, Principal, Kathryn Stein Consulting; formerly Director of the Division of Monocolonal Antibodies FDA and SVP Product Development and Regulatory Affairs, Macrogenics
5:00 - 6:00pmClosing Reception with Cocktails